Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP52962.RA9Cxa_bRq5dM_rBCfXWAkMf-DtATc_3_ZDytLUW5pt38130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP52962.RA9Cxa_bRq5dM_rBCfXWAkMf-DtATc_3_ZDytLUW5pt38130_assertion type Assertion NP52962.RA9Cxa_bRq5dM_rBCfXWAkMf-DtATc_3_ZDytLUW5pt38130_head.
- NP52962.RA9Cxa_bRq5dM_rBCfXWAkMf-DtATc_3_ZDytLUW5pt38130_assertion description "[The prevalence of activated protein C (APC) resistance and factor V Leiden is significantly higher in patients with retinal vein occlusion without general risk factors. Case-control study and meta-analysis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP52962.RA9Cxa_bRq5dM_rBCfXWAkMf-DtATc_3_ZDytLUW5pt38130_provenance.
- NP52962.RA9Cxa_bRq5dM_rBCfXWAkMf-DtATc_3_ZDytLUW5pt38130_assertion evidence source_evidence_literature NP52962.RA9Cxa_bRq5dM_rBCfXWAkMf-DtATc_3_ZDytLUW5pt38130_provenance.
- NP52962.RA9Cxa_bRq5dM_rBCfXWAkMf-DtATc_3_ZDytLUW5pt38130_assertion SIO_000772 18449423 NP52962.RA9Cxa_bRq5dM_rBCfXWAkMf-DtATc_3_ZDytLUW5pt38130_provenance.
- NP52962.RA9Cxa_bRq5dM_rBCfXWAkMf-DtATc_3_ZDytLUW5pt38130_assertion wasDerivedFrom gad-20150221 NP52962.RA9Cxa_bRq5dM_rBCfXWAkMf-DtATc_3_ZDytLUW5pt38130_provenance.
- NP52962.RA9Cxa_bRq5dM_rBCfXWAkMf-DtATc_3_ZDytLUW5pt38130_assertion wasGeneratedBy ECO_0000203 NP52962.RA9Cxa_bRq5dM_rBCfXWAkMf-DtATc_3_ZDytLUW5pt38130_provenance.